US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 24.840
  • -0.370-1.47%
Close Dec 13 16:00 ET
  • 24.950
  • +0.110+0.44%
Post 20:01 ET
11.04BMarket Cap9.78P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.68%703.61M
8.29%658.21M
-35.71%664.64M
39.36%2.99B
35.57%772.63M
6.44%573.52M
5.72%607.82M
124.62%1.03B
6.27%2.14B
16.32%569.93M
Net income from continuing operations
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-81.46%230.06M
-1,236.61%-610.03M
Operating gains losses
-30.08%-655.1M
21.74%-513.66M
13.00%-605.13M
-17.05%-2.54B
-31.83%-686.82M
4.19%-503.6M
-1.03%-656.35M
-46.20%-695.57M
-8.08%-2.17B
-11.41%-521M
Depreciation and amortization
----
----
----
--0
----
----
----
----
-75.34%5.67M
--0
Other non cash items
11.78%798.16M
11.53%667.88M
-35.15%752.35M
30.43%3.24B
19.00%769.85M
7.93%714.03M
7.29%598.84M
87.23%1.16B
8.59%2.49B
11.76%646.94M
Change In working capital
49.43%-18.72M
33.09%50.08M
31.62%-29.5M
-83.52%5.38M
92.04%47.91M
-19.51%-37.02M
-52.00%37.63M
-8.62%-43.14M
300.11%32.66M
-45.81%24.95M
-Change in receivables
50.76%-1.32M
-142.10%-1.35M
114.83%178K
-96.64%1.07M
198.97%1.74M
-632.34%-2.68M
-89.45%3.21M
-147.98%-1.2M
208.82%31.71M
-133.78%-1.75M
-Change in payables and accrued expense
71.84%-10.64M
8.92%43.65M
-1.16%-42.7M
400.96%3.76M
33.32%43.67M
-2.04%-37.78M
-13.77%40.08M
2.86%-42.21M
-111.38%-1.25M
-14.95%32.76M
-Change in other current assets
-178.60%-2.7M
148.51%2.74M
4,637.45%13.03M
-74.57%559K
141.30%2.5M
-37.93%3.44M
-485.09%-5.66M
-77.86%275K
18.36%2.2M
-359.87%-6.06M
-Change in other current liabilities
---4.06M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
22.68%703.61M
8.29%658.21M
-35.71%664.64M
39.36%2.99B
35.57%772.63M
6.44%573.52M
5.72%607.82M
124.62%1.03B
6.27%2.14B
16.32%569.93M
Investing cash flow
Cash flow from continuing investing activities
-164.66%-1.19B
-1,308.06%-893.18M
84.49%-86.65M
-101.35%-2.07B
-341.16%-1B
68.38%-450.66M
-110.20%-63.43M
-5,102.47%-558.53M
44.96%-1.03B
175.18%414.74M
Net business purchase and sale
--0
-33.38%-3.98M
-94.78%-6.97M
-26.74%-12.54M
---1.99M
41.81%-3.98M
---2.99M
-17.34%-3.58M
71.61%-9.9M
--0
Net investment purchase and sale
-166.93%-1.2B
-1,298.23%-845.17M
85.34%-84.64M
-104.97%-2.09B
-341.31%-1B
68.19%-451.13M
-100.30%-60.45M
-4,161.30%-577.31M
43.90%-1.02B
176.08%414.74M
Net other investing changes
--1K
----
----
---14.44M
---2.04M
--0
--0
---12.4M
----
----
Cash from discontinued investing activities
Investing cash flow
-164.66%-1.19B
-1,308.06%-893.18M
84.49%-86.65M
-101.35%-2.07B
-341.16%-1B
68.38%-450.66M
-110.20%-63.43M
-5,102.47%-558.53M
44.96%-1.03B
175.18%414.74M
Financing cash flow
Cash flow from continuing financing activities
76.06%-325.51M
433.32%1.16B
-0.77%-212M
-127.42%-2.15B
12.67%-231.89M
-490.86%-1.36B
-52.02%-347M
4.79%-210.37M
-345.35%-944.86M
-34.07%-265.55M
Net issuance payments of debt
--0
----
----
---1B
--0
---1B
----
----
--0
--0
Net common stock issuance
30.74%-97.05M
----
----
---304.76M
---30.2M
---140.12M
----
----
--0
--0
Cash dividends paid
-4.80%-94.06M
-4.79%-94.94M
-5.84%-93.81M
-7.50%-358.33M
-6.10%-89.34M
-7.09%-89.75M
-9.10%-90.61M
-7.74%-88.63M
-16.88%-333.32M
-14.40%-84.2M
Net other financing activities
-3.68%-134.4M
-14.54%-139.68M
2.91%-118.19M
20.58%-485.67M
38.04%-112.36M
11.39%-129.62M
16.02%-121.95M
12.23%-121.74M
-1.54%-611.53M
-45.70%-181.35M
Cash from discontinued financing activities
Financing cash flow
76.06%-325.51M
433.32%1.16B
-0.77%-212M
-127.42%-2.15B
12.67%-231.89M
-490.86%-1.36B
-52.02%-347M
4.79%-210.37M
-345.35%-944.86M
-34.07%-265.55M
Net cash flow
Beginning cash position
-18.80%1.76B
-57.33%843M
-72.12%477.01M
11.01%1.71B
-5.56%936.45M
3.09%2.17B
10.28%1.98B
11.01%1.71B
52.78%1.54B
-44.93%991.63M
Current changes in cash
34.13%-814.59M
366.92%921.64M
38.14%365.99M
-827.00%-1.23B
-163.89%-459.44M
-10.77%-1.24B
-37.64%197.39M
5.78%264.94M
-68.12%169.7M
376.84%719.12M
End cash Position
1.45%950.05M
-18.80%1.76B
-57.33%843M
-72.12%477.01M
-72.12%477.01M
-5.56%936.45M
3.09%2.17B
10.28%1.98B
11.01%1.71B
11.01%1.71B
Free cash flow
22.68%703.61M
8.29%658.21M
-35.71%664.64M
39.36%2.99B
35.57%772.63M
6.44%573.52M
5.72%607.82M
124.62%1.03B
6.27%2.14B
16.32%569.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.68%703.61M8.29%658.21M-35.71%664.64M39.36%2.99B35.57%772.63M6.44%573.52M5.72%607.82M124.62%1.03B6.27%2.14B16.32%569.93M
Net income from continuing operations 560.53%806.36M-44.67%194.38M-100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M-81.46%230.06M-1,236.61%-610.03M
Operating gains losses -30.08%-655.1M21.74%-513.66M13.00%-605.13M-17.05%-2.54B-31.83%-686.82M4.19%-503.6M-1.03%-656.35M-46.20%-695.57M-8.08%-2.17B-11.41%-521M
Depreciation and amortization --------------0-----------------75.34%5.67M--0
Other non cash items 11.78%798.16M11.53%667.88M-35.15%752.35M30.43%3.24B19.00%769.85M7.93%714.03M7.29%598.84M87.23%1.16B8.59%2.49B11.76%646.94M
Change In working capital 49.43%-18.72M33.09%50.08M31.62%-29.5M-83.52%5.38M92.04%47.91M-19.51%-37.02M-52.00%37.63M-8.62%-43.14M300.11%32.66M-45.81%24.95M
-Change in receivables 50.76%-1.32M-142.10%-1.35M114.83%178K-96.64%1.07M198.97%1.74M-632.34%-2.68M-89.45%3.21M-147.98%-1.2M208.82%31.71M-133.78%-1.75M
-Change in payables and accrued expense 71.84%-10.64M8.92%43.65M-1.16%-42.7M400.96%3.76M33.32%43.67M-2.04%-37.78M-13.77%40.08M2.86%-42.21M-111.38%-1.25M-14.95%32.76M
-Change in other current assets -178.60%-2.7M148.51%2.74M4,637.45%13.03M-74.57%559K141.30%2.5M-37.93%3.44M-485.09%-5.66M-77.86%275K18.36%2.2M-359.87%-6.06M
-Change in other current liabilities ---4.06M------------------0----------------
Cash from discontinued investing activities
Operating cash flow 22.68%703.61M8.29%658.21M-35.71%664.64M39.36%2.99B35.57%772.63M6.44%573.52M5.72%607.82M124.62%1.03B6.27%2.14B16.32%569.93M
Investing cash flow
Cash flow from continuing investing activities -164.66%-1.19B-1,308.06%-893.18M84.49%-86.65M-101.35%-2.07B-341.16%-1B68.38%-450.66M-110.20%-63.43M-5,102.47%-558.53M44.96%-1.03B175.18%414.74M
Net business purchase and sale --0-33.38%-3.98M-94.78%-6.97M-26.74%-12.54M---1.99M41.81%-3.98M---2.99M-17.34%-3.58M71.61%-9.9M--0
Net investment purchase and sale -166.93%-1.2B-1,298.23%-845.17M85.34%-84.64M-104.97%-2.09B-341.31%-1B68.19%-451.13M-100.30%-60.45M-4,161.30%-577.31M43.90%-1.02B176.08%414.74M
Net other investing changes --1K-----------14.44M---2.04M--0--0---12.4M--------
Cash from discontinued investing activities
Investing cash flow -164.66%-1.19B-1,308.06%-893.18M84.49%-86.65M-101.35%-2.07B-341.16%-1B68.38%-450.66M-110.20%-63.43M-5,102.47%-558.53M44.96%-1.03B175.18%414.74M
Financing cash flow
Cash flow from continuing financing activities 76.06%-325.51M433.32%1.16B-0.77%-212M-127.42%-2.15B12.67%-231.89M-490.86%-1.36B-52.02%-347M4.79%-210.37M-345.35%-944.86M-34.07%-265.55M
Net issuance payments of debt --0-----------1B--0---1B----------0--0
Net common stock issuance 30.74%-97.05M-----------304.76M---30.2M---140.12M----------0--0
Cash dividends paid -4.80%-94.06M-4.79%-94.94M-5.84%-93.81M-7.50%-358.33M-6.10%-89.34M-7.09%-89.75M-9.10%-90.61M-7.74%-88.63M-16.88%-333.32M-14.40%-84.2M
Net other financing activities -3.68%-134.4M-14.54%-139.68M2.91%-118.19M20.58%-485.67M38.04%-112.36M11.39%-129.62M16.02%-121.95M12.23%-121.74M-1.54%-611.53M-45.70%-181.35M
Cash from discontinued financing activities
Financing cash flow 76.06%-325.51M433.32%1.16B-0.77%-212M-127.42%-2.15B12.67%-231.89M-490.86%-1.36B-52.02%-347M4.79%-210.37M-345.35%-944.86M-34.07%-265.55M
Net cash flow
Beginning cash position -18.80%1.76B-57.33%843M-72.12%477.01M11.01%1.71B-5.56%936.45M3.09%2.17B10.28%1.98B11.01%1.71B52.78%1.54B-44.93%991.63M
Current changes in cash 34.13%-814.59M366.92%921.64M38.14%365.99M-827.00%-1.23B-163.89%-459.44M-10.77%-1.24B-37.64%197.39M5.78%264.94M-68.12%169.7M376.84%719.12M
End cash Position 1.45%950.05M-18.80%1.76B-57.33%843M-72.12%477.01M-72.12%477.01M-5.56%936.45M3.09%2.17B10.28%1.98B11.01%1.71B11.01%1.71B
Free cash flow 22.68%703.61M8.29%658.21M-35.71%664.64M39.36%2.99B35.57%772.63M6.44%573.52M5.72%607.82M124.62%1.03B6.27%2.14B16.32%569.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List